clavulanic acid has been researched along with cefpodoxime proxetil in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bingen, E; Rangaraj, M; Safran, C | 1 |
Fiessinger, S; Gehanno, P; Ichou, F; Pelc, A; Portier, H | 1 |
Gandhi, SV; Patil, NG; Patil, UP | 1 |
Dubala, A; George, R; Nagarajan, JS; Vimal, CS | 1 |
1 trial(s) available for clavulanic acid and cefpodoxime proxetil
Article | Year |
---|---|
Cost saving of 5-day therapy with cefpodoxime proxetil versus standard 10-day beta-lactam therapy for recurrent pharyngotonsillitis in adults. A prospective general practice study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cefpodoxime Proxetil; Ceftizoxime; Clavulanic Acid; Clavulanic Acids; Cost-Benefit Analysis; Drug Therapy, Combination; Family Practice; France; Humans; Penicillin V; Pharyngitis; Prodrugs; Recurrence; Tonsillitis; Treatment Outcome | 1996 |
3 other study(ies) available for clavulanic acid and cefpodoxime proxetil
Article | Year |
---|---|
Ribotyping differentiates relapse from reinfection in the treatment failures of Escherichia coli urinary tract infections in children.
Topics: Amoxicillin; Cefpodoxime Proxetil; Ceftizoxime; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Diagnosis, Differential; DNA, Ribosomal; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Humans; Infant; Recurrence; Treatment Failure; Urinary Tract Infections | 1994 |
Simultaneous spectrophotometric determination of Cefpodoxime proxetil and Potassium clavulanate.
Topics: Anti-Bacterial Agents; Cefpodoxime Proxetil; Ceftizoxime; Clavulanic Acid; Spectrophotometry, Ultraviolet; Tablets | 2009 |
Simultaneous quantification of cefpodoxime proxetil and clavulanic acid in human plasma by LC-MS using solid phase extraction with application to pharmacokinetic studies.
Topics: Anti-Bacterial Agents; Cefpodoxime Proxetil; Ceftizoxime; Chromatography, Liquid; Clavulanic Acid; Humans; Mass Spectrometry; Sensitivity and Specificity; Solid Phase Extraction | 2013 |